Orthopediatrics Corp (NASDAQ:KIDS) Receives $47.00 Average PT from Analysts

Orthopediatrics Corp (NASDAQ:KIDS) has received an average recommendation of “Buy” from the six brokerages that are currently covering the company, MarketBeat.com reports. Three analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $47.00.

Several analysts have recently weighed in on KIDS shares. ValuEngine downgraded shares of Orthopediatrics from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Zacks Investment Research downgraded shares of Orthopediatrics from a “buy” rating to a “hold” rating in a research note on Tuesday. BTIG Research reaffirmed a “buy” rating and set a $44.00 price target on shares of Orthopediatrics in a research note on Friday, May 10th. Needham & Company LLC started coverage on shares of Orthopediatrics in a research note on Wednesday, June 19th. They set a “buy” rating and a $53.00 price target for the company. Finally, BidaskClub raised shares of Orthopediatrics from a “sell” rating to a “hold” rating in a research note on Friday, August 2nd.

NASDAQ KIDS traded down $0.14 during trading on Wednesday, hitting $30.14. The stock had a trading volume of 90,880 shares, compared to its average volume of 78,210. The company has a debt-to-equity ratio of 0.26, a current ratio of 8.60 and a quick ratio of 6.01. The stock has a market cap of $442.40 million, a PE ratio of -31.40 and a beta of 0.12. Orthopediatrics has a one year low of $25.11 and a one year high of $47.82. The firm’s 50 day moving average price is $35.24.

Orthopediatrics (NASDAQ:KIDS) last announced its quarterly earnings data on Wednesday, August 7th. The company reported ($0.14) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.09) by ($0.05). The firm had revenue of $18.20 million during the quarter, compared to the consensus estimate of $18.44 million. Orthopediatrics had a negative return on equity of 13.90% and a negative net margin of 15.77%. The firm’s revenue for the quarter was up 20.5% on a year-over-year basis. During the same period in the previous year, the business earned ($0.21) EPS. On average, sell-side analysts expect that Orthopediatrics will post -0.44 EPS for the current fiscal year.

Several institutional investors have recently bought and sold shares of the company. Metropolitan Life Insurance Co. NY bought a new position in Orthopediatrics in the fourth quarter worth approximately $93,000. American Century Companies Inc. bought a new position in Orthopediatrics in the fourth quarter worth approximately $3,880,000. Bank of New York Mellon Corp raised its stake in Orthopediatrics by 14.3% in the fourth quarter. Bank of New York Mellon Corp now owns 21,500 shares of the company’s stock worth $750,000 after buying an additional 2,697 shares in the last quarter. BlackRock Inc. raised its stake in Orthopediatrics by 12.4% in the fourth quarter. BlackRock Inc. now owns 455,657 shares of the company’s stock worth $15,894,000 after buying an additional 50,179 shares in the last quarter. Finally, Geode Capital Management LLC raised its stake in Orthopediatrics by 51.9% in the fourth quarter. Geode Capital Management LLC now owns 80,310 shares of the company’s stock worth $2,801,000 after buying an additional 27,429 shares in the last quarter. 49.45% of the stock is owned by hedge funds and other institutional investors.

About Orthopediatrics

OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, RESPONSE Spine systems, Bandloc, and Pediguard.

See Also: How to calculate the intrinsic value of a stock

Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit